» Articles » PMID: 36983181

Multi-Mechanistic Approaches to the Treatment of Traumatic Brain Injury: A Review

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 Mar 29
PMID 36983181
Authors
Affiliations
Soon will be listed here.
Abstract

Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Despite extensive research efforts, the majority of trialed monotherapies to date have failed to demonstrate significant benefit. It has been suggested that this is due to the complex pathophysiology of TBI, which may possibly be addressed by a combination of therapeutic interventions. In this article, we have reviewed combinations of different pharmacologic treatments, combinations of non-pharmacologic interventions, and combined pharmacologic and non-pharmacologic interventions for TBI. Both preclinical and clinical studies have been included. While promising results have been found in animal models, clinical trials of combination therapies have not yet shown clear benefit. This may possibly be due to their application without consideration of the evolving pathophysiology of TBI. Improvements of this paradigm may come from novel interventions guided by multimodal neuromonitoring and multimodal imaging techniques, as well as the application of multi-targeted non-pharmacologic and endogenous therapies. There also needs to be a greater representation of female subjects in preclinical and clinical studies.

Citing Articles

Extracellular cold-inducible RNA-binding protein in CNS injury: molecular insights and therapeutic approaches.

Lapin D, Sharma A, Wang P J Neuroinflammation. 2025; 22(1):12.

PMID: 39838468 PMC: 11752631. DOI: 10.1186/s12974-025-03340-7.


Calcium and Non-Penetrating Traumatic Brain Injury: A Proposal for the Implementation of an Early Therapeutic Treatment for Initial Head Insults.

ODay D Biomolecules. 2024; 14(7).

PMID: 39062567 PMC: 11274459. DOI: 10.3390/biom14070853.


Mitochondria-Targeted Antioxidant Therapeutics for Traumatic Brain Injury.

Modi H, Musyaju S, Ratcliffe M, Shear D, Scultetus A, Pandya J Antioxidants (Basel). 2024; 13(3).

PMID: 38539837 PMC: 10967339. DOI: 10.3390/antiox13030303.


Traumatic Brain Injury Recovery with Photobiomodulation: Cellular Mechanisms, Clinical Evidence, and Future Potential.

Lim L Cells. 2024; 13(5.

PMID: 38474349 PMC: 10931349. DOI: 10.3390/cells13050385.

References
1.
Yasmin A, Pitkanen A, Jokivarsi K, Poutiainen P, Grohn O, Immonen R . MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex - A 6-Months Multimodal Imaging Follow-Up Study. Front Neurosci. 2019; 13:863. PMC: 6707062. DOI: 10.3389/fnins.2019.00863. View

2.
Kota D, Prabhakara K, Van Brummen A, Bedi S, Xue H, DiCarlo B . Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury. Stem Cells Transl Med. 2015; 5(1):33-44. PMC: 4704870. DOI: 10.5966/sctm.2015-0065. View

3.
Torres-Querol C, Quintana-Luque M, Arque G, Purroy F . Preclinical evidence of remote ischemic conditioning in ischemic stroke, a metanalysis update. Sci Rep. 2021; 11(1):23706. PMC: 8660795. DOI: 10.1038/s41598-021-03003-6. View

4.
Smith C, Gentleman S, Leclercq P, Murray L, Griffin W, Graham D . The neuroinflammatory response in humans after traumatic brain injury. Neuropathol Appl Neurobiol. 2012; 39(6):654-66. PMC: 3833642. DOI: 10.1111/nan.12008. View

5.
Lu M, Wang Y, Yin X, Li Y, Li H . Cerebral protection by remote ischemic post-conditioning in patients with ischemic stroke: A systematic review and meta-analysis of randomized controlled trials. Front Neurol. 2022; 13:905400. PMC: 9532592. DOI: 10.3389/fneur.2022.905400. View